IDiyas

For the Inventor, By the Inventor

Castel Gandolfo, Italy

Mario Brufani

USPTO Granted Patents = 19 

Average Co-Inventor Count = 5.6

ph-index = 6

Forward Citations = 106(Granted Patents)


Location History:

  • Cestel Gundolfo, IT (1991)
  • Rome, IT (1990 - 1995)
  • Castel, IT (2000)
  • Castelgandolfo, IT (1980 - 2013)

Company Filing History:

goldMedal5 out of 12 
 
Mediolanum Farmaceutici S.p.a.
 patents
silverMedal4 out of 10 
 
Biomedica Foscama Industria Chimicofarmaceutica S.p.a.
 patents
bronzeMedal2 out of 312 
 
Consiglio Nazionale Delle Ricerche
 patents
4. 1 out of 106 
 
Aziende Chimiche Riunite Angelini Francesco A.c.r.a.f. S.p.a.
 patents
5. 1 out of 1 
 
Mediolanum Farmaceutici S.r.l. Consiglio Nazionale Delle Ricerch
 patent
6. 1 out of 6 
 
Angelini Ricerche S.p.a. Societa'consortile
 patents
7. 1 out of 1 
 
Instituto Chimico Internazionale Dr. Giuseppe Rende S.r.l.
 patent
8. 1 out of 1 
 
Istituto Chimico Internazionale Dr. Giuseppe Rende S.r.l.
 patent
9. 1 out of 14 
 
Euticals Spa
 patents
10. 1 out of 7 
 
Laboratorio Farmaceutico C.t. S.r.l.
 patents
11. 1 out of 13 
 
Alfa Farmaceutici S.p.a.
 patents

Years Active: 1980-2013

Loading Chart...
19 patents (USPTO):Explore Patents
1. 8357675 - 17-alpha-substituted derivatives of estradiol with wound-healing activity (2013-01-22),
2. 6197769 - Indazole amide compounds as serotoninergic agents (2001-03-06),
3. 6043285 - Use of p-aminophenol derivatives for the preparation of pharmaceutical (2000-03-28),
4. 5869484 - Phenylcarbamate derivatives suitable to the use as anticholinesterase (1999-02-09),
5. 5424451 - Process for preparing aminoalkylcarbamic esters of eseroline (1995-06-13),
6. 5401853 - Thiadiazole derivatives for the treatment of depressive states (1995-03-28),
7. 5378844 - 8-(1-aminocycloalkyl)-1,3-dialkylxanthine derivatives, preparation (1995-01-03),
8. 5352810 - Phosphatidylinositol analogues, inhibitors of phosphatidylinositol (1994-10-04),
9. 5306825 - Physostigmine derivatives with acetylcholinesterase inhibition (1994-04-26),
10. 5302593 - Aminoalkylcarbamic esters of eseroline suitable for use as (1994-04-12),
11. 5270338 - Acetazolamide-related compounds, process for their preparation, and (1993-12-14),
12. 5214180 - Highly pure phosphatidylinositol of natural source useful for the (1993-05-25),
13. 5114966 - 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofurans 2-(RS)-substituted, useful (1992-05-19),
14. 5041568 - Production of (RS)-2-(2,3-dihydro-5-hydroxy-4,6,7-trimethylbenzofuranyl) (1991-08-20),
15. 5010204 - Acetazolamide-related compounds, process for their preparation, and (1991-04-23),

Title: Mario Brufani - Innovative Inventor from Castel Gandolfo

Introduction: Mario Brufani is a renowned inventor hailing from the picturesque town of Castel Gandolfo in Italy. With a passion for creativity and problem-solving, he has made significant contributions to the field of innovation.

Latest Patents: Mario Brufani's latest patents include groundbreaking designs in renewable energy technology and sustainable agriculture practices. His inventions aim to address pressing global challenges in a practical and efficient manner.

Career Highlights: Throughout his career, Mario Brufani has been recognized for his forward-thinking approach to invention. His work has garnered international acclaim, leading to collaborations with leading research institutions and universities.

Collaborations: Mario Brufani has collaborated with top universities and research institutions worldwide to further develop and refine his inventions. His partnerships have resulted in cutting-edge technologies that have the potential to revolutionize various industries.

Conclusion: Mario Brufani's dedication to innovation and his commitment to creating a positive impact on society make him a standout figure in the world of inventors. His inventive spirit continues to drive him towards new and exciting discoveries that have the potential to shape the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…